4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001780660-25-000002
Chief People Officer sold 113,890 shares at $15.57 ($1,773,267)
- Chief People Officer acquired 97,022 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
LO FRANCIS · Chief People Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +37,750 | $7.80 | $294,450 | 370,596 | D |
| 2025-12-15 | Exercise or conversion : show line 2 in the form 10b5-1 | +19,423 | $8.46 | $164,319 | 390,019 | D |
| 2025-12-15 | Exercise or conversion : show line 3 in the form 10b5-1 | +39,849 | $3.99 | $158,998 | 429,868 | D |
| 2025-12-15 | Sale : show line 4 in the form 10b5-1 | −113,890 | $15.57 | $1,773,267 | 315,978 | D |
| Open-market sales · 113,890 sh · avg $15.57 · $1,773,267 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-15 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −37,750 | 113,250 | D |
| 2025-12-15 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −19,423 | 109,176 | D |
| 2025-12-15 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) | −39,849 | 110,175 | D |
Loading xslF345X05/primary_doc.xml…